Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a multi-center retrospective study.

BMC Cancer · 2025 · PMC12007349 · PMID 40247248

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

showed a trendp = 0.058so close (0.05 < p ≤ 0.1)

In the overall population, the group receiving OFS in the high CR-score (CR-score above 1.42) cohort showed a trend towards improved DFS compared to the non-OFS group ( p = 0.058, Fig. 4 A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.